Keshav R. Gandhi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Keshav R. Gandhi has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Gutfraind
The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago
2 shared publications Alexander Gutfraind
The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, 2160 S. First Ave., Maywood, IL 60153, United States; Division of Epidemiology and Biostatistics, School of Public Health, University of Illinois at Chicago, 1603 W. Taylor St., Chicago, IL 60612, United States
1 shared publication- Basmattee Boodram
University of Illinois Chicago
1 shared publication - Christina E. Fliege
National Center for Supercomputing Applications, Genomics Group, Urbana, IL, United States, 61801
1 shared publication - Eric Tatara
University of Chicago; Argonne National Laboratory
1 shared publication Harel Dahari
The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, 2160 S. First Ave., Maywood, IL 60153, United States
1 shared publication
Latest Publications
- Open Access
Modeling spontaneous hepatitis C virus clearance by age, sex, IFNL4 genotype, and infection history: Implications for simulations of elimination and vaccine trials
Background and Aims: The probability of hepatitis C virus (HCV) clearance is mediated by an interaction between numerous factors. However, variation in spontaneous HCV clearance was previously modeled using relatively simple approaches with fixed probabilities by sex. Here, we developed a literature-informed clearance algorithm that considers age, sex, interferon lambda 4 (IFNL4) genotype, and infection history to model the probability of HCV clearance in vulnerable populations, such as people who inject drugs (PWID), and in controlled human infection (CHI) models for future HCV vaccines. Methods: We modeled HCV clearance probabilities for three infection-history pathways: first infection, reinfection after spontaneous clearance, and reinfection after direct-acting antiviral (DAA) cure. Logistic and cumulative-hazard equations assigned person-specific clearance probabilities in the first two pathways. The post-DAA pathway used fixed clearance probabilities. We tested the algorithm using HepCEP (Hepatitis C Elimination in PWID), an agent-based simulator. Results: First-infection clearance probabilities ranged from 0.13 to 0.51 across eight age, sex, and IFNL4 genotype subgroups. Clearance probabilities for reinfection after spontaneous clearance ranged from 0.20 to 0.80 at literature point estimates. Across 100 runs, the mean assigned clearance probabilities were 0.27 for first infections and 0.52 for reinfections after spontaneous clearance, compared with literature inputs of 0.26 and 0.52, respectively. Probabilities varied across subgroups and runs. Conclusion: Simulations reproduced the algorithm's intended clearance heterogeneity and uncertainty by age, sex, IFNL4 genotype, and infection history, which may support models of HCV elimination in vulnerable populations and CHI model development for future HCV vaccines.
Open AccessModeling spontaneous hepatitis C virus clearance by age, sex, IFNL4 genotype, and infection history: Implications for simulations of elimination and vaccine trials
Background and Aims: The probability of hepatitis C virus (HCV) clearance is mediated by an interaction between numerous factors. However, variation in spontaneous HCV clearance was previously modeled using relatively simple approaches with fixed probabilities by sex. Here, we developed a literature-informed clearance algorithm that considers age, sex, interferon lambda 4 (IFNL4) genotype, and infection history to model the probability of HCV clearance in vulnerable populations, such as people who inject drugs (PWID), and in controlled human infection (CHI) models for future HCV vaccines. Methods: We modeled HCV clearance probabilities for three infection-history pathways: first infection, reinfection after spontaneous clearance, and reinfection after direct-acting antiviral (DAA) cure. Logistic and cumulative-hazard equations assigned person-specific clearance probabilities in the first two pathways. The post-DAA pathway used fixed clearance probabilities. We tested the algorithm using HepCEP (Hepatitis C Elimination in PWID), an agent-based simulator. Results: First-infection clearance probabilities ranged from 0.13 to 0.51 across eight age, sex, and IFNL4 genotype subgroups. Clearance probabilities for reinfection after spontaneous clearance ranged from 0.20 to 0.80 at literature point estimates. Across 100 runs, the mean assigned clearance probabilities were 0.27 for first infections and 0.52 for reinfections after spontaneous clearance, compared with literature inputs of 0.26 and 0.52, respectively. Probabilities varied across subgroups and runs. Conclusion: Simulations reproduced the algorithm's intended clearance heterogeneity and uncertainty by age, sex, IFNL4 genotype, and infection history, which may support models of HCV elimination in vulnerable populations and CHI model development for future HCV vaccines.
- Open Access
- 4 May 2026
- Published by The Open Journal in Journal of Open Source Software
- Vol. 11 (121) , 9056
Enhancing short-read sequencing simulation: Updates to NEAT
- 4 May 2026
- Published by The Open Journal in Journal of Open Source Software
- Vol. 11 (121) , 9056
Open AccessEnhancing short-read sequencing simulation: Updates to NEAT
- Open Access
Modern approaches to predicting vaccine hesitancy: A scoping review
Introduction Motivated by the disproportionate burden of infectious diseases on vulnerable populations and the risk of future pandemics, we conducted a scoping review to analyze the state of the literature about “vaccine uptake indices,” defined as models that predict vaccination rates by geospatial area. We analyzed novel vaccine uptake indices created in response to the recent COVID-19 pandemic. The aim of this scoping review is to survey the state of the literature regarding vaccine uptake indices relating to COVID-19 and other infectious diseases. Methods We conducted a scoping review with a systematic search strategy to identify relevant articles from the databases Embase, PubMed, and Web of Science with title and abstract screening, full-text review, and data extraction. Results Database searches resulted in 3,615 potential articles, of which 229 reports were included. Fifteen studies (7%) were determined to be methodologically advanced vaccine uptake indices that had at least three of the following characteristics: the use of individual- and population-level predictor variables (100 [44%]), geo-spatiotemporal analysis (58 [25%]), data usage agnostic to vaccine specificity (50 [22%]), or sociobehavioral frameworks of health (such as the Health Belief Model and Theory of Planned Behavior) (30 [13%]). Conclusion This scoping review offers suggestions for future research of next-generation vaccine uptake indices before use in vaccination campaigns of recurring or novel infectious diseases. Areas to pursue include utilizing individual-level data about vaccination behaviors in conjunction with administrative data, solving the challenge of implementing small-area spatiotemporal analysis, using vaccine-agnostic methods that consider data from more than one infectious disease, and assisting causal inference with theoretical frameworks.
Open AccessModern approaches to predicting vaccine hesitancy: A scoping review
Introduction Motivated by the disproportionate burden of infectious diseases on vulnerable populations and the risk of future pandemics, we conducted a scoping review to analyze the state of the literature about “vaccine uptake indices,” defined as models that predict vaccination rates by geospatial area. We analyzed novel vaccine uptake indices created in response to the recent COVID-19 pandemic. The aim of this scoping review is to survey the state of the literature regarding vaccine uptake indices relating to COVID-19 and other infectious diseases. Methods We conducted a scoping review with a systematic search strategy to identify relevant articles from the databases Embase, PubMed, and Web of Science with title and abstract screening, full-text review, and data extraction. Results Database searches resulted in 3,615 potential articles, of which 229 reports were included. Fifteen studies (7%) were determined to be methodologically advanced vaccine uptake indices that had at least three of the following characteristics: the use of individual- and population-level predictor variables (100 [44%]), geo-spatiotemporal analysis (58 [25%]), data usage agnostic to vaccine specificity (50 [22%]), or sociobehavioral frameworks of health (such as the Health Belief Model and Theory of Planned Behavior) (30 [13%]). Conclusion This scoping review offers suggestions for future research of next-generation vaccine uptake indices before use in vaccination campaigns of recurring or novel infectious diseases. Areas to pursue include utilizing individual-level data about vaccination behaviors in conjunction with administrative data, solving the challenge of implementing small-area spatiotemporal analysis, using vaccine-agnostic methods that consider data from more than one infectious disease, and assisting causal inference with theoretical frameworks.